NRXP
NRX Pharmaceuticals Inc
3.40$
+1.2%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
NRX Pharmaceuticals Inc (NRXP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -14 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -0.1 | -0.5 | -0.8 | -2.3 | -38 | -40 | -22 | -11 | -14 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | – | 0.0 | 0.7 | 7.8 | 3.6 | 0.4 | 0.5 | 0.2 | |
| – | – | 1.3 | 46 | 60 | – | – | – | – | |
| 0.0 | 0.5 | 0.0 | 3.5 | -4.9 | 0.7 | 5.2 | 5.3 | 1.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -69 | -0.6 | 40 | 0.0 | 0.0 | 0.0 | 0.0 | – | -2.8 | |
| 70 | – | -41 | -26 | – | – | – | – | – | |
| – | – | 0.6 | 0.6 | -1.3 | 9.5 | -3.1 | -1.5 | 4.7 | |
| 70 | 0.7 | -39 | 3.2 | 63 | 32 | 6.2 | 7.5 | 23 | |
| 0.4 | -0.4 | 0.0 | 1.0 | 26 | -7.6 | -15 | -3.2 | 6.4 | |
| -0.1 | -0.5 | -0.8 | -2.3 | -38 | -40 | -22 | -11 | -14 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.